{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T14:04:22Z","timestamp":1787321062655,"version":"build-2736575974"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Herzzentrum G\u00f6ttingen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Physical activity and exercise have been classified as safe and effective in mild to moderate cases of myasthenia gravis (MG) across various studies. Subsequently, adequate physical activity is generally recommended. Nevertheless, individuals with MG remain less physically active than the general population, without a precise definition of the low-activity group so far.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this prospective single-center study, individuals with MG completed a questionnaire assessing general mobility, weekly physical activity levels, and beliefs toward specific statements about physical exercise. These data were contextualized with clinical parameters and MG-specific scores.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 84 individuals (50% female), 73.8% reported general positive effects, and 77.4% noted improvements in mood and well-being due to physical activity. No significant differences in physical activity levels were found depending on sex, BMI or age. Weekly physical activity averaged 94.6\u00a0min (SD: 85.6), falling below current recommendations. Physical activity was inversely correlated with lower QMG (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.019) and MG-ADL scores (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.004). Despite the reported positive impact of physical activity on quality of life, no relevant connection was detected between physical activity and MG-QoL15 scores.\n                    <\/jats:p>\n                    <jats:p>\n                      Barriers preventing individuals affected by MG from engaging in physical activity included muscle pain (35.4%) and motivational challenges (22%). Individuals with motivational problems were younger (mean age 55.5 vs. 66.6 years,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.011) and more frequently reported depressive symptoms; no other significant differences were observed in gender or disease severity in this subgroup.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Individuals with MG perceive physical activity as beneficial to their physical well-being, mood, and overall quality of life. Those with less severe disease tend to be more active. However, barriers such as motivational issues and post-exercise pain must be addressed. Clinicians should aim to identify individuals with low activity levels, encourage engagement in physical activity, highlight its benefits, and alleviate patient concerns.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>Study approval by the Ethics Committee of the University Medical Center G\u00f6ttingen was granted (number 33\/12\/21). The study was retrospectively registered at the German Clinical Trial Registry (DRKS) under the study ID DRKS00033171 (Date of trial registration December 1st, 2023).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-025-04590-x","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T06:06:50Z","timestamp":1765951610000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Physical activity and its effects in myasthenia gravis: a patient-reported study on habits and impact"],"prefix":"10.1186","volume":"26","author":[{"given":"Stefanie","family":"Glaubitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Loris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Kummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Garfias-Veitl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariana","family":"Seraji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Hassoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Rohleder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Hunger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Zsch\u00fcntzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"4590_CR1","doi-asserted-by":"crossref","unstructured":"Ekelund U, Tarp J, Steene-Johannessen J, Hansen BH, Jefferis B, Fagerland MW, et al. Dose-response associations between accelerometry measured physical activity and sedentary time and all cause mortality: systematic review and harmonised meta-analysis. BMJ. 2019; 366:l4570.","DOI":"10.1136\/bmj.l4570"},{"key":"4590_CR2","unstructured":"World Health Organisation. WHO guidelines on physical activity and sedatary Behaivor. Recommendations. Geneva: World Health Organisation; 2020."},{"key":"4590_CR3","unstructured":"World Health Organisation. Physical activity. 2024. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/physical-activity."},{"issue":"2","key":"4590_CR4","first-page":"126","volume":"100","author":"CJ Caspersen","year":"1985","unstructured":"Caspersen CJ, Powell KE, Christenson GM. Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep. 1985;100(2):126\u201331.","journal-title":"Public Health Rep"},{"issue":"1","key":"4590_CR5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.autrev.2017.11.010","volume":"17","author":"K Sharif","year":"2018","unstructured":"Sharif K, Watad A, Bragazzi NL, Lichtbroun M, Amital H, Shoenfeld Y. Physical activity and autoimmune diseases: get moving and manage the disease. Autoimmun Rev. 2018;17(1):53\u201372.","journal-title":"Autoimmun Rev"},{"issue":"26","key":"4590_CR6","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1056\/NEJMra1602678","volume":"375","author":"NE Gilhus","year":"2016","unstructured":"Gilhus NE. Myasthenia Gravis. N Engl J Med. 2016;375(26):2570\u201381.","journal-title":"N Engl J Med"},{"issue":"8","key":"4590_CR7","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s00415-016-8045-z","volume":"263","author":"N Melzer","year":"2016","unstructured":"Melzer N, Ruck T, Fuhr P, Gold R, Hohlfeld R, Marx A, et al. Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the guidelines of the German neurological society. J Neurol. 2016;263(8):1473\u201394.","journal-title":"J Neurol"},{"issue":"6","key":"4590_CR8","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1056\/NEJMoa1602489","volume":"375","author":"GI Wolfe","year":"2016","unstructured":"Wolfe GI, Kaminski HJ, Aban IB, Minisman G, Kuo HC, Marx A, et al. Randomized trial of thymectomy in myasthenia Gravis. N Engl J Med. 2016;375(6):511\u201322.","journal-title":"N Engl J Med"},{"issue":"5","key":"4590_CR9","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S1474-4422(23)00077-7","volume":"22","author":"V Bril","year":"2023","unstructured":"Bril V, Dru\u017cd\u017c A, Grosskreutz J, Habib AA, Mantegazza R, Sacconi S, et al. Safety and efficacy of Rozanolixizumab in patients with generalised myasthenia Gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study. Lancet Neurol. 2023;22(5):383\u201394.","journal-title":"Lancet Neurol"},{"issue":"7","key":"4590_CR10","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/S1474-4422(21)00159-9","volume":"20","author":"JF Howard","year":"2021","unstructured":"Howard JF, Bril V, Vu T, Karam C, Peric S, Margania T, et al. Safety, efficacy, and tolerability of Efgartigimod in patients with generalised myasthenia Gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial. Lancet Neurol. 2021;20(7):526\u201336.","journal-title":"Lancet Neurol"},{"issue":"5","key":"4590_CR11","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S1474-4422(23)00080-7","volume":"22","author":"JF Howard","year":"2023","unstructured":"Howard JF, Bresch S, Genge A, Hewamadduma C, Hinton J, Hussain Y, et al. Safety and efficacy of Zilucoplan in patients with generalised myasthenia Gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study. Lancet Neurol. 2023;22(5):395\u2013406.","journal-title":"Lancet Neurol"},{"issue":"4","key":"4590_CR12","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1007\/s00415-022-11517-w","volume":"270","author":"F Sacc\u00e0","year":"2023","unstructured":"Sacc\u00e0 F, Barnett C, Vu T, Peric S, Phillips GA, Zhao S, et al. Efgartigimod improved health-related quality of life in generalized myasthenia gravis: results from a randomized, double-blind, placebo-controlled, phase 3 study (ADAPT). J Neurol. 2023;270(4):2096\u2013105.","journal-title":"J Neurol"},{"key":"4590_CR13","doi-asserted-by":"publisher","first-page":"103033","DOI":"10.1016\/j.ctim.2024.103033","volume":"81","author":"S Peng","year":"2024","unstructured":"Peng S, Meng L, Fang R, Shen Q, Tian Y, Xiong A, et al. Current state of research on exercise for the treatment of myasthenia gravis: A scoping review. Complement Ther Med. 2024;81:103033.","journal-title":"Complement Ther Med"},{"issue":"3","key":"4590_CR14","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.nmd.2020.12.004","volume":"31","author":"NE Gilhus","year":"2021","unstructured":"Gilhus NE. Physical training and exercise in myasthenia Gravis. Neuromuscul Disord. 2021;31(3):169\u201373.","journal-title":"Neuromuscul Disord"},{"key":"4590_CR15","doi-asserted-by":"crossref","unstructured":"O\u2019Connor L, Westerberg E, Punga AR. Myasthenia Gravis and physical exercise: a novel paradigm. Front Neurol. 2020;11:675.","DOI":"10.3389\/fneur.2020.00675"},{"issue":"1","key":"4590_CR16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3233\/JND-180355","volume":"6","author":"L O\u2019Connor","year":"2018","unstructured":"O\u2019Connor L, Westerberg E, Punga AR. Pattern of habitual physical exercise in myasthenia Gravis patients. J Neuromuscul Dis. 2018;6(1):85\u201391.","journal-title":"J Neuromuscul Dis"},{"issue":"4","key":"4590_CR17","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3233\/JND-210637","volume":"8","author":"S Birnbaum","year":"2021","unstructured":"Birnbaum S, Bachasson D, Sharshar T, Porcher R, Hogrel JY, Portero P. Free-Living physical activity and sedentary behaviour in autoimmune myasthenia gravis: A Cross-Sectional study. J Neuromuscul Dis. 2021;8(4):689\u201397.","journal-title":"J Neuromuscul Dis"},{"issue":"8","key":"4590_CR18","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.nmd.2021.05.007","volume":"31","author":"LK Andersen","year":"2021","unstructured":"Andersen LK, Aadahl M, Vissing J. Fatigue, physical activity and associated factors in 779 patients with myasthenia Gravis. Neuromuscul Disord. 2021;31(8):716\u201325.","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"4590_CR19","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3233\/JND-210693","volume":"9","author":"LK Andersen","year":"2022","unstructured":"Andersen LK, Vissing J. Habitual physical activity in patients with myasthenia Gravis assessed by accelerometry and questionnaire. JND. 2022;9(1):161\u20139.","journal-title":"JND"},{"key":"4590_CR20","doi-asserted-by":"crossref","unstructured":"Wiendl H, Meisel A et al., Diagnostik und herapie myasthener Syndrome, S2k-Leitlinie. Deutsche Gesellschaft f\u00fcr Neurologie (DGN); 2022. Available from: www.dgn.org\/leitlinien.","DOI":"10.1007\/s42451-023-00568-6"},{"issue":"7","key":"4590_CR21","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1212\/WNL.52.7.1487","volume":"52","author":"GI Wolfe","year":"1999","unstructured":"Wolfe GI, Herbelin L, Nations SP, Foster B, Bryan WW, Barohn RJ. Myasthenia Gravis activities of daily living profile. Neurology. 1999;52(7):1487\u20139.","journal-title":"Neurology"},{"key":"4590_CR22","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/j.1749-6632.1998.tb11015.x","volume":"841","author":"RJ Barohn","year":"1998","unstructured":"Barohn RJ, McIntire D, Herbelin L, Wolfe GI, Nations S, Bryan WW. Reliability testing of the quantitative myasthenia Gravis score. Ann N Y Acad Sci. 1998;841:769\u201372.","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"4590_CR23","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1002\/mus.21053","volume":"38","author":"TM Burns","year":"2008","unstructured":"Burns TM, Conaway MR, Cutter GR, Sanders DB, Muscle Study Group. Less is more, or almost as much: a 15-item quality-of-life instrument for myasthenia Gravis. Muscle Nerve. 2008;38(2):957\u201363.","journal-title":"Muscle Nerve"},{"issue":"1","key":"4590_CR24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jshs.2023.10.010","volume":"13","author":"SD Herrmann","year":"2024","unstructured":"Herrmann SD, Willis EA, Ainsworth BE, Barreira TV, Hastert M, Kracht CL, et al. 2024 adult compendium of physical activities: A third update of the energy costs of human activities. J Sport Health Sci. 2024;13(1):6\u201312.","journal-title":"J Sport Health Sci"},{"issue":"3","key":"4590_CR25","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1159\/000513668","volume":"84","author":"UK Misra","year":"2021","unstructured":"Misra UK, Kalita J, Singh VK, Kapoor A, Tripathi A, Mishra P. Rest or 30-Min walk as exercise intervention (RESTOREX) in myasthenia gravis: A randomized controlled trial. Eur Neurol. 2021;84(3):168\u201374.","journal-title":"Eur Neurol"},{"issue":"6","key":"4590_CR26","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1007\/s12035-023-03247-5","volume":"60","author":"GM Tripathi","year":"2023","unstructured":"Tripathi GM, Misra UK, Kalita J, Singh VK, Tripathi A. Effect of exercise on \u03b2-Endorphin and its receptors in myasthenia Gravis patients. Mol Neurobiol. 2023;60(6):3010\u20139.","journal-title":"Mol Neurobiol"},{"issue":"26","key":"4590_CR27","doi-asserted-by":"publisher","first-page":"8442","DOI":"10.1080\/09638288.2021.2022221","volume":"44","author":"AN Ceren","year":"2022","unstructured":"Ceren AN, Salc\u0131 Y, Fil Balkan A, \u00c7al\u0131k K\u00fct\u00fck\u00e7\u00fc E, Armutlu K, Erdem \u00d6zdamar S. The effects of spinal stabilization exercises in patients with myasthenia gravis: a randomized crossover study. Disabil Rehabil. 2022;44(26):8442\u20139.","journal-title":"Disabil Rehabil"},{"issue":"4","key":"4590_CR28","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/mus.25552","volume":"56","author":"MA Rahbek","year":"2017","unstructured":"Rahbek MA, Mikkelsen EE, Overgaard K, Vinge L, Andersen H, Dalgas U. Exercise in myasthenia gravis: A feasibility study of aerobic and resistance training. Muscle Nerve. 2017;56(4):700\u20139.","journal-title":"Muscle Nerve"},{"issue":"17","key":"4590_CR29","doi-asserted-by":"publisher","first-page":"4031","DOI":"10.3390\/jcm10174031","volume":"10","author":"CC Chang","year":"2021","unstructured":"Chang CC, Chen YK, Chiu HC, Yeh JH. Changes in physical fitness and body composition associated with physical exercise in patients with myasthenia gravis: A longitudinal prospective study. JCM. 2021;10(17):4031.","journal-title":"JCM"},{"issue":"5","key":"4590_CR30","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1002\/mus.24054","volume":"49","author":"SH Wong","year":"2014","unstructured":"Wong SH, Nitz JC, Williams K, Brauer SG. Effects of balance strategy training in myasthenia gravis: A case study series. Muscle Nerve. 2014;49(5):654\u201360.","journal-title":"Muscle Nerve"},{"issue":"8","key":"4590_CR31","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.nmd.2021.05.002","volume":"31","author":"S Birnbaum","year":"2021","unstructured":"Birnbaum S, Porcher R, Portero P, Clair B, Demeret S, Eymard B, et al. Home-based exercise in autoimmune myasthenia gravis: A randomized controlled trial. Neuromuscul Disord. 2021;31(8):726\u201335.","journal-title":"Neuromuscul Disord"},{"issue":"31","key":"4590_CR32","doi-asserted-by":"publisher","first-page":"e11510","DOI":"10.1097\/MD.0000000000011510","volume":"97","author":"E Westerberg","year":"2018","unstructured":"Westerberg E, Molin CJ, Sp\u00f6rndly Nees S, Widenfalk J, Punga AR. The impact of physical exercise on neuromuscular function in myasthenia Gravis patients: A single-subject design study. Medicine. 2018;97(31):e11510.","journal-title":"Medicine"},{"key":"4590_CR33","doi-asserted-by":"crossref","unstructured":"Chen S, Li X, Wu Y, Li Y, Cao P, Yin Y et al. Preoperative respiratory muscle training combined with aerobic exercise improves respiratory vital capacity and daily life activity following surgical treatment for myasthenia Gravis. J Cardiothorac Surg. 2023;18(1):160.","DOI":"10.1186\/s13019-023-02283-5"},{"issue":"2","key":"4590_CR34","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/mus.25493","volume":"56","author":"E Westerberg","year":"2017","unstructured":"Westerberg E, Molin CJ, Lindblad I, Emtner M, Punga AR. Physical exercise in myasthenia Gravis is safe and improves neuromuscular parameters and physical performance-based measures: A pilot study: physical exercise in MG. Muscle Nerve. 2017;56(2):207\u201314.","journal-title":"Muscle Nerve"},{"key":"4590_CR35","doi-asserted-by":"publisher","first-page":"S82","DOI":"10.1016\/j.nmd.2022.07.171","volume":"32","author":"S Birnbaum","year":"2022","unstructured":"Birnbaum S, Archer A, Stalens C, Lejeune J, Hogrel J. VP.40 exploring barriers and facilitators to physical exercise in autoimmune myasthenia gravis: the MYaEX study. Neuromuscul Disord. 2022;32:S82\u20133.","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"4590_CR36","doi-asserted-by":"publisher","first-page":"e2840","DOI":"10.1002\/brb3.2840","volume":"13","author":"J Nadali","year":"2023","unstructured":"Nadali J, Ghavampour N, Beiranvand F, Maleki Takhtegahi M, Heidari ME, Salarvand S, et al. Prevalence of depression and anxiety among myasthenia Gravis (MG) patients: A systematic review and meta-analysis. Brain Behav. 2023;13(1):e2840.","journal-title":"Brain Behav"},{"issue":"1","key":"4590_CR37","doi-asserted-by":"publisher","first-page":"19275","DOI":"10.1038\/s41598-022-22078-3","volume":"12","author":"D Marbin","year":"2022","unstructured":"Marbin D, Piper SK, Lehnerer S, Harms U, Meisel A. Mental health in myasthenia Gravis patients and its impact on caregiver burden. Sci Rep. 2022;12(1):19275.","journal-title":"Sci Rep"},{"issue":"8","key":"4590_CR38","doi-asserted-by":"publisher","first-page":"5665","DOI":"10.1007\/s00415-024-12490-2","volume":"271","author":"M Funke","year":"2024","unstructured":"Funke M, Eveslage M, Zsch\u00fcntzsch J, Hagenacker T, Ruck T, Schubert C, et al. Fatigue and associated factors in myasthenia gravis: a nationwide registry study. J Neurol. 2024;271(8):5665\u201370.","journal-title":"J Neurol"},{"issue":"8","key":"4590_CR39","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.nmd.2020.06.010","volume":"30","author":"AM Ruiter","year":"2020","unstructured":"Ruiter AM, Verschuuren JJGM, Tannemaat MR. Fatigue in patients with myasthenia gravis. A systematic review of the literature. Neuromuscul Disord. 2020;30(8):631\u20139.","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"4590_CR40","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40263-023-01059-8","volume":"38","author":"S Crisafulli","year":"2024","unstructured":"Crisafulli S, Boccanegra B, Carollo M, Bottani E, Mantuano P, Trifir\u00f2 G, et al. Myasthenia Gravis treatment: from old drugs to innovative therapies with a glimpse into the future. CNS Drugs. 2024;38(1):15\u201332.","journal-title":"CNS Drugs"},{"issue":"10","key":"4590_CR41","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1176\/appi.ajp.2014.13091264","volume":"171","author":"LL Judd","year":"2014","unstructured":"Judd LL, Schettler PJ, Brown ES, Wolkowitz OM, Sternberg EM, Bender BG, et al. Adverse consequences of glucocorticoid medication: Psychological, Cognitive, and behavioral effects. AJP. 2014;171(10):1045\u201351.","journal-title":"AJP"},{"key":"4590_CR42","doi-asserted-by":"publisher","first-page":"1108062","DOI":"10.3389\/fspor.2023.1108062","volume":"5","author":"A Riiser","year":"2023","unstructured":"Riiser A, Stensrud T, Andersen LB. Glucocorticoids and physical performance: A systematic review with meta-analysis of randomized controlled trials. Front Sports Act Living. 2023;5:1108062.","journal-title":"Front Sports Act Living"},{"key":"4590_CR43","unstructured":"EuropeanLeague Against Rheumatism. Exercise improves functional and psychological ability and reduces steroid need in rheumatoid arthritis. 2009. (Science Daily). Available. from: www.sciencedaily.com\/releases\/2009\/06\/090611110820.htm."},{"issue":"3","key":"4590_CR44","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.amjcard.2017.10.033","volume":"121","author":"BA Franklin","year":"2018","unstructured":"Franklin BA, Brinks J, Berra K, Lavie CJ, Gordon NF, Sperling LS. Using metabolic equivalents in clinical practice. Am J Cardiol. 2018;121(3):382\u20137.","journal-title":"Am J Cardiol"},{"issue":"3","key":"4590_CR45","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jad.2008.01.009","volume":"110","author":"AL Vaccarino","year":"2008","unstructured":"Vaccarino AL, Sills TL, Evans KR, Kalali AH. Prevalence and association of somatic symptoms in patients with major depressive disorder. J Affect Disord. 2008;110(3):270\u20136.","journal-title":"J Affect Disord"},{"issue":"2","key":"4590_CR46","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/S0163-8343(02)00277-3","volume":"25","author":"K Sayar","year":"2003","unstructured":"Sayar K, Kirmayer LJ, Taillefer SS. Predictors of somatic symptoms in depressive disorder. Gen Hosp Psychiatry. 2003;25(2):108\u201314.","journal-title":"Gen Hosp Psychiatry"},{"key":"4590_CR47","doi-asserted-by":"publisher","first-page":"903","DOI":"10.3389\/fpsyt.2019.00903","volume":"10","author":"Y Wang","year":"2019","unstructured":"Wang Y, He Y, Wang G, Li J, Zhu H. Correlation analysis between attentional bias and somatic symptoms in depressive disorders. Front Psychiatry. 2019;10:903.","journal-title":"Front Psychiatry"},{"issue":"8","key":"4590_CR48","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1017\/S0033291716003548","volume":"47","author":"SA Hiles","year":"2017","unstructured":"Hiles SA, Lamers F, Milaneschi Y, Penninx BWJH. Sit, step, sweat: longitudinal associations between physical activity patterns, anxiety and depression. Psychol Med. 2017;47(8):1466\u201377.","journal-title":"Psychol Med"},{"key":"4590_CR49","doi-asserted-by":"crossref","unstructured":"Rodriguez RD, Anderson AEL, Gwathmey KG, Brethenoux CR, Shea LM, Govindarajan R, et al. Mental health experiences and challenges among individuals with myasthenia gravis: insights from Patient-Centered, qualitative analyses. Adv Ther. 2025; 42(12):6209-6233.","DOI":"10.1007\/s12325-025-03399-x"},{"key":"4590_CR50","doi-asserted-by":"publisher","first-page":"975482","DOI":"10.3389\/fpubh.2022.975482","volume":"10","author":"D Marbin","year":"2022","unstructured":"Marbin D, Gutwinski S, Schreiter S, Heinz A. Perspectives in poverty and mental health. Front Public Health. 2022;10:975482.","journal-title":"Front Public Health"},{"issue":"1","key":"4590_CR51","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/mus.26719","volume":"61","author":"MH Alanazy","year":"2020","unstructured":"Alanazy MH, Binabbad RS, Alromaih NI, Almansour RA, Alanazi SN, Alhamdi MF, et al. Severity and depression can impact quality of life in patients with myasthenia Gravis. Muscle Nerve. 2020;61(1):69\u201373.","journal-title":"Muscle Nerve"},{"issue":"11","key":"4590_CR52","doi-asserted-by":"publisher","first-page":"e0206754","DOI":"10.1371\/journal.pone.0206754","volume":"13","author":"A Jeong","year":"2018","unstructured":"Jeong A, Min JH, Kang YK, Kim J, Choi M, Seok JM, et al. Factors associated with quality of life of people with myasthenia Gravis. PLoS ONE. 2018;13(11):e0206754.","journal-title":"PLoS ONE"},{"issue":"3","key":"4590_CR53","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1212\/WNL.0000000000011124","volume":"96","author":"P Narayanaswami","year":"2021","unstructured":"Narayanaswami P, Sanders DB, Wolfe G, Benatar M, Cea G, Evoli A, et al. International consensus guidance for management of myasthenia gravis: 2020 update. Neurology. 2021;96(3):114\u201322.","journal-title":"Neurology"},{"issue":"1","key":"4590_CR54","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3233\/JND-210722","volume":"9","author":"T Alsop","year":"2022","unstructured":"Alsop T, Williams K, Gomersall S. Physical activity and sedentary behaviour in people with myasthenia gravis: a cross-sectional study. JND. 2022;9(1):137\u201346.","journal-title":"JND"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04590-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04590-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04590-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T12:04:43Z","timestamp":1768997083000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-025-04590-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4590"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04590-x","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"assertion":[{"value":"11 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"approval of the study by the Ethics Committee of the University Medical Center G\u00f6ttingen was granted on January 05, 2022 (application number: 33\/12\/21). All patients gave their written informed consent for the study participation. All procedures were carried out in accordance with the ethical principles of the Declaration of Helsinki. The study was registered at the WHO-licensed German clinical trial registry (DRKS00033171).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SG received speaker\u00b4s honoraria for lecturing from Argenx, Alexion and UCB and travel, accommodation and congress fees from Grifols, UCB and Alexion. SM received speaker\u00b4s honoraria for lecturing from Argenx, and travel, accommodation and congress fees from Biotest, Kedrion, Alnylam Pharmaceuticals, Argenx und Janssen. RZ has received honoraria from Argenx as well as travel expenses to attend congresses from Biogen, LFB, and Octapharma. AS has received honoraria from Argenx. KK received speaker\u00b4s honoraria for lecturing and travel, accommodation and congress fees from Argenx, Alexion and UCB. JZ received speaker\u00b4s honoraria for lecturing from: Alexion, Amicus, Argenx, Kedrion, Roche, Sanofi and UCB and travel, accommodation and congress fees from Alexion, Argenx, Janssen, Kedrion, Sanofi and UCB. Research was granted from Argenx and UCB. JZ is board member of the German Myasthenia Association and member of the German Muscle Society. JL, LH, DR, IH and TGV declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}